Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Feb 02, 2023 6:42am
122 Views
Post# 35261506

Truth

Truth Who remembers raza bokhari touting $1 salary 

whi remembers only 1 patient tested during covid trial and no recruitment status update during his reign as ceo

whi remembers Steven buyer and was charged by sec 

that god AD and zeeshan were able to prevent total loss raza tried to sue fsd for 30 million and arbitration amd courts sided with FSD and shareholders 

now that's the past now it's on current management to grow the company which includes brain fried sleepless nights to grow the company

dr Kotra is the brains behind clinical teams at fsd Pharma they have incentive now with options package if they wanna make real money , we need to see real results as a whole form the company I believe the tides of change are here this could be the year if they prove with clinical trial assets good things going forward


good luck to all
<< Previous
Bullboard Posts
Next >>